Greg Haug

817 total citations
27 papers, 411 citations indexed

About

Greg Haug is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases and Physiology. According to data from OpenAlex, Greg Haug has authored 27 papers receiving a total of 411 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 6 papers in Infectious Diseases and 5 papers in Physiology. Recurrent topics in Greg Haug's work include Chronic Obstructive Pulmonary Disease (COPD) Research (12 papers), Pulmonary Hypertension Research and Treatments (8 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers). Greg Haug is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (12 papers), Pulmonary Hypertension Research and Treatments (8 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers). Greg Haug collaborates with scholars based in Australia, Canada and India. Greg Haug's co-authors include Sukhwinder Singh Sohal, Mathew Suji Eapen, Collin Chia, Josie Larby, James Markos, Stephen Myers, Heinrich C. Weber, Wenying Lu, Archana Vijay Gaikwad and Surajit Dey and has published in prestigious journals such as PLoS ONE, Cochrane Database of Systematic Reviews and Frontiers in Immunology.

In The Last Decade

Greg Haug

25 papers receiving 408 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Greg Haug Australia	13	235	88	76	60	48	27	411
Collin Chia Australia	13	291 1.2×	69 0.8×	75 1.0×	105 1.8×	39 0.8×	26	465
Rongli Lu China	10	123 0.5×	75 0.9×	127 1.7×	35 0.6×	63 1.3×	25	342
Konstantinos Loverdos Greece	9	180 0.8×	88 1.0×	63 0.8×	48 0.8×	34 0.7×	14	320
Masaharu Shinkai Japan	12	252 1.1×	30 0.3×	62 0.8×	78 1.3×	87 1.8×	37	392
Chunling Du China	10	88 0.4×	137 1.6×	51 0.7×	72 1.2×	47 1.0×	26	351
Mohammad Shameem India	9	139 0.6×	67 0.8×	42 0.6×	84 1.4×	56 1.2×	73	371
Shujin Guo China	12	131 0.6×	47 0.5×	64 0.8×	16 0.3×	59 1.2×	35	371
Sotirios Kakavas Greece	12	131 0.6×	20 0.2×	53 0.7×	94 1.6×	30 0.6×	30	339
Xiaoyan Gai China	11	130 0.6×	68 0.8×	92 1.2×	41 0.7×	40 0.8×	39	337
Lucas Kimmig United States	11	128 0.5×	177 2.0×	108 1.4×	43 0.7×	74 1.5×	20	543

Countries citing papers authored by Greg Haug

Since Specialization

Citations

This map shows the geographic impact of Greg Haug's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Greg Haug with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Greg Haug more than expected).

Fields of papers citing papers by Greg Haug

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Greg Haug. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Greg Haug. The network helps show where Greg Haug may publish in the future.

Co-authorship network of co-authors of Greg Haug

This figure shows the co-authorship network connecting the top 25 collaborators of Greg Haug. A scholar is included among the top collaborators of Greg Haug based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Greg Haug. Greg Haug is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Simón, A., et al.. (2025). Pathophysiology of small airways in idiopathic pulmonary fibrosis (IPF): the silent zone. Expert Review of Respiratory Medicine. 19(3). 195–203.

Dey, Surajit, Wenying Lu, Prabuddha S. Pathinayake, et al.. (2025). Epithelial-to-mesenchymal transition is an active process in the large airways of patients with asthma-COPD overlap and partially abrogated by inhaled corticosteroid treatment: a bronchoscopy endobronchial biopsy study. Frontiers in Immunology. 16. 1531279–1531279. 1 indexed citations

Teoh, Alan, et al.. (2024). Pathology of idiopathic pulmonary fibrosis with particular focus on vascular endothelium and epithelial injury and their therapeutic potential. Pharmacology & Therapeutics. 265. 108757–108757. 9 indexed citations

Larby, Josie, Melinda E. Wilson, Jade Jaffar, et al.. (2024). Patients with idiopathic pulmonary fibrosis have fatty lungs impacting respiratory physiology. Pulmonology. 31(1). 2424637–2424637. 1 indexed citations

Brake, Samuel James, Wenying Lu, Collin Chia, et al.. (2023). Transforming growth factor-β1 and SMAD signalling pathway in the small airways of smokers and patients with COPD: potential role in driving fibrotic type-2 epithelial mesenchymal transition. Frontiers in Immunology. 14. 1216506–1216506. 13 indexed citations

Gaikwad, Archana Vijay, Wenying Lu, Surajit Dey, et al.. (2023). Endothelial-to-mesenchymal transition: a precursor to pulmonary arterial remodelling in patients with idiopathic pulmonary fibrosis. ERJ Open Research. 9(2). 487–2022. 17 indexed citations

Dey, Surajit, Wenying Lu, Greg Haug, et al.. (2023). Airway inflammatory changes in the lungs of patients with asthma-COPD overlap (ACO): a bronchoscopy endobronchial biopsy study. Respiratory Research. 24(1). 221–221. 11 indexed citations

Brake, Samuel James, Mathew Suji Eapen, Kielan Darcy McAlinden, et al.. (2022). SARS-CoV-2 (COVID-19) Adhesion Site Protein Upregulation in Small Airways, Type 2 Pneumocytes, and Alveolar Macrophages of Smokers and COPD &ndash; Possible Implications for Interstitial Fibrosis. Dove Medical Press (Taylor and Francis Group). 11 indexed citations

Gaikwad, Archana Vijay, Wenying Lu, Surajit Dey, et al.. (2022). Vascular remodelling in idiopathic pulmonary fibrosis patients and its detrimental effect on lung physiology: potential role of endothelial-to-mesenchymal transition. ERJ Open Research. 8(1). 571–2021. 28 indexed citations

10.

Bhattarai, Prem, Wenying Lu, Archana Vijay Gaikwad, et al.. (2022). Arterial remodelling in smokers and in patients with small airway disease and COPD: implications for lung physiology and early origins of pulmonary hypertension. ERJ Open Research. 8(4). 254–2022. 18 indexed citations

11.

Dey, Surajit, Wenying Lu, Heinrich C. Weber, et al.. (2022). Differential airway remodeling changes were observed in patients with asthma COPD overlap compared to patients with asthma and COPD alone. American Journal of Physiology-Lung Cellular and Molecular Physiology. 323(4). L473–L483. 12 indexed citations

12.

Lu, Wenying, Mathew Suji Eapen, Gurpreet K. Singhera, et al.. (2022). Angiotensin-Converting Enzyme 2 (ACE2), Transmembrane Peptidase Serine 2 (TMPRSS2), and Furin Expression Increases in the Lungs of Patients with Idiopathic Pulmonary Fibrosis (IPF) and Lymphangioleiomyomatosis (LAM): Implications for SARS-CoV-2 (COVID-19) Infections. Journal of Clinical Medicine. 11(3). 777–777. 5 indexed citations

13.

McAlinden, Kielan Darcy, Wenying Lu, Stephen Myers, et al.. (2021). Electronic Cigarette Aerosol Is Cytotoxic and Increases ACE2 Expression on Human Airway Epithelial Cells: Implications for SARS-CoV-2 (COVID-19). Journal of Clinical Medicine. 10(5). 1028–1028. 26 indexed citations

14.

Asrani, Purva, Mathew Suji Eapen, Kielan Darcy McAlinden, et al.. (2021). Clinical features and mechanistic insights into drug repurposing for combating COVID-19. The International Journal of Biochemistry & Cell Biology. 142. 106114–106114. 11 indexed citations

15.

Bhattarai, Prem, James Markos, Collin Chia, et al.. (2021). Increased arterial remodelling in smokers and mild-moderate COPD patients are indicative of potential early onset of pulmonary hypertension. OA1216–OA1216. 3 indexed citations

16.

Gaikwad, Archana Vijay, Mathew Suji Eapen, Kielan Darcy McAlinden, et al.. (2020). Endothelial to mesenchymal transition (EndMT) and vascular remodeling in pulmonary hypertension and idiopathic pulmonary fibrosis. Expert Review of Respiratory Medicine. 14(10). 1027–1043. 60 indexed citations

17.

Asrani, Purva, Mathew Suji Eapen, Collin Chia, et al.. (2020). Diagnostic approaches in COVID-19: clinical updates. Expert Review of Respiratory Medicine. 15(2). 197–212. 38 indexed citations

18.

Eapen, Mathew Suji, Wenying Lu, Tillie‐Louise Hackett, et al.. (2020). Dysregulation of endocytic machinery and ACE2 in small airways of smokers and COPD patients can augment their susceptibility to SARS-CoV-2 (COVID-19) infections. American Journal of Physiology-Lung Cellular and Molecular Physiology. 320(1). L158–L163. 18 indexed citations

19.

Gautam, Sanjay, Micheál Mac Aogáin, Louise Cooley, et al.. (2018). Molecular epidemiology of tuberculosis in Tasmania and genomic characterisation of its first known multi-drug resistant case. PLoS ONE. 13(2). e0192351–e0192351. 15 indexed citations

20.

Eapen, Mathew Suji, Philip M. Hansbro, Anna‐Karin Larsson‐Callerfelt, et al.. (2018). Chronic Obstructive Pulmonary Disease and Lung Cancer: Underlying Pathophysiology and New Therapeutic Modalities. Drugs. 78(16). 1717–1740. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact